Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
89 pending office actions • 59 art units • 89 examiners • 0 of 89 (0%) have an AI response strategy ready • 75 patents granted in the last 365 days
Regents of the University of Minnesota is managing 90 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 88 distinct examiners and 47 distinct art units. This indicates a large and diverse portfolio with many different individuals and specialized groups involved. The 47 distinct art units show that the university's research covers a vast array of technical classifications within the biotech and pharmaceutical sectors.
PATEL, RONAK C is the busiest examiner, with 2 pending office actions. The other pending actions are spread among the other distinct examiners. With 88 distinct examiners involved, the university faces a high degree of variability in how its applications are reviewed. The 47 distinct art units for 90 actions indicate that while some specialized groups handle multiple applications, the individual examiners within those groups are mostly unique. Practitioners must manage separate prosecution tracks, as the high number of examiners limits the ability to reuse successful negotiation tactics across the portfolio.
Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 10 (11%) |
| §103 only | 23 (26%) |
| §112 only | 3 (3%) |
| Double-patenting only | 2 (2%) |
| Double-patenting + other | 7 (8%) |
| Multi-statute (no §101) | 42 (47%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHEN, YANXIN NMN | 1 | 84.6% | +26.4% |
| YANG, YI-SHAN | 1 | 70.4% | +53.0% |
| STANLEY, TYLER JAY | 1 | 48.5% | +51.5% |
| NUR, ABDULLAHI | 1 | 88.2% | +6.1% |
| ORKIN, ALEXANDER J | 1 | 65.5% | +26.8% |
| ZAKARIA, AKM | 1 | 82.5% | +16.2% |
| BOMAR, THOMAS S | 1 | 83.0% | +0.2% |
| HILSMIER, HEIDI ANN | 1 | 53.8% | +65.9% |
| PATEL, TULSIDAS C | 1 | 42.9% | +22.8% |
| ARIANI, KADE | 1 | 75.0% | +32.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19228322 | HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE | NUR, ABDULLAHI | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18109039 | Cardiopulmonary Resuscitation Catheter and Related Systems and Methods | GRAY, PHILLIP A | 126d overdue |
| 18501663 | DEVICE FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND RELATED SYSTEMS AND METHODS | SIRCAR, ALISHA JITENDRA | 98d overdue |
| 18000258 | COPOLYMERS FOR INTRACELLULAR THERAPEUTIC NUCLEIC ACID PAYLOAD DELIVERY | SASTRI, SATYA B | 66d overdue |
| 18579604 | MONITORING AND CLASSIFICATION OF CARDIAC ARREST RHYTHM | DIETRICH, JOSEPH M | 31d overdue |
| 18337578 | LOCAL VOLT/VAR CONTROLLERS WITH STABILITY GUARANTEES | YOON, ERIC | 5d overdue |
| 18639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | MCDOWELL, BRIAN E | 3d overdue |
| 19041455 | WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF | PATEL, TULSIDAS C | 2d overdue |
| 17953981 | NON-FIBRILLAR HEMOGLOBIN S OLIGOMERS AND METHODS TO IDENTIFY MODULATORS OF HEMOGLOBIN S POLYMERIZATION | TURK, NEIL N | 8d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19041455 | WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF | PATEL, TULSIDAS C | 2d overdue |
| 19326385 | ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS | SHEN, YANXIN NMN | — |
| 19153797 | MULTIMODAL ULTRASOUND AND ACOUSTIC SYSTEM AND METHOD FOR NOVEL NON-INVASIVE HEARING ASSESSMENT AND INTRACRANIAL PRESSURE MONITORING | YANG, YI-SHAN | — |
| 19236658 | Multi-Speed Ergonomic Wheelchair And Devices And Methods Therefor | STANLEY, TYLER JAY | — |
| 19184578 | PULMONARY ARTERY FLOW RESTRICTOR | ORKIN, ALEXANDER J | — |
| 19182191 | MAGNETIC RESONANCE IMAGE RECONSTRUCTION WITH DEEP LEARNING-BASED OUTER VOLUME REMOVAL | ZAKARIA, AKM | — |
| 19061008 | ATRIAL FIBRILLATION INSTABILITY DIAGNOSIS AND TREATMENT | HILSMIER, HEIDI ANN | — |
| 18961073 | COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT | ARIANI, KADE | — |
| Art Unit | Apps |
|---|---|
| 3796 | 5 |
| 1632 | 4 |
| 3783 | 4 |
| 3774 | 3 |
| 1641 | 3 |
| 1796 | 3 |
| 1663 | 2 |
| 2877 | 2 |
| 3771 | 2 |
| 2896 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19326385 | ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS | SHEN, YANXIN NMN | 1663 | §102§103§112 | Non-Final OA | — | Pending | Sep 11, 2025 |
| 19153797 | MULTIMODAL ULTRASOUND AND ACOUSTIC SYSTEM AND METHOD FOR NOVEL NON-INVASIVE HEARING ASSESSMENT AND INTRACRANIAL PRESSURE MONITORING | YANG, YI-SHAN | 3798 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 05, 2025 |
| 19236658 | Multi-Speed Ergonomic Wheelchair And Devices And Methods Therefor | STANLEY, TYLER JAY | 3611 | §102§103§112 | Non-Final OA | — | Pending | Jun 12, 2025 |
| 19228322 | HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE | NUR, ABDULLAHI | 2877 | §103Other | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19184578 | PULMONARY ARTERY FLOW RESTRICTOR | ORKIN, ALEXANDER J | 3771 | §103 | Final Rejection | — | Pending | Apr 21, 2025 |
| 19182191 | MAGNETIC RESONANCE IMAGE RECONSTRUCTION WITH DEEP LEARNING-BASED OUTER VOLUME REMOVAL | ZAKARIA, AKM | 2858 | §102§103 | Non-Final OA | — | Pending | Apr 17, 2025 |
| 19120136 | BURROWING ROBOT AND BURROWING ROBOT HEAD | BOMAR, THOMAS S | 3674 | §102§112Other | Non-Final OA | — | Pending | Apr 10, 2025 |
| 19061008 | ATRIAL FIBRILLATION INSTABILITY DIAGNOSIS AND TREATMENT | HILSMIER, HEIDI ANN | 3796 | §101 | Non-Final OA | — | Pending | Feb 24, 2025 |
| 19041455 | WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF | PATEL, TULSIDAS C | 2896 | §102§103 | Non-Final OA | 2d overdue | Pending | Jan 30, 2025 |
| 18961073 | COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT | ARIANI, KADE | 1651 | §103§112DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18916866 | SILICA-COATED STIMULUS-RESPONSIVE POLYMERIC NANOPARTICLES | PATEL, RONAK C | 1788 | §103 | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18915826 | METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN | MOLOYE, TITILAYO | 1632 | DP | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18903394 | MULTI-MODAL SYNCHRONIZATION THERAPY | STICE, PAULA J | 3796 | §101§112DP | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18846873 | THERAPEUTIC COMPOUND AND SALTS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18818917 | MOTOR UNIT CHIP, MANUFACTURING METHOD THEREOF AND METHOD OF DETECTING PATHOLOGICAL EVENT USING THE SAME | KELLY, ROBERT M | 1638 | §102§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18832026 | ANTI-B7-H3 COMPOUNDS AND METHODS OF USE | LIPPERT, JOHN WILLIAM | 1615 | §102§103 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18726717 | HEMOSTATIC COMPOSITION CONTAINING RECOMBINANT HUMAN CLOTTING FACTORS, AND METHOD OF PRODUCING | RAMIREZ, DELIA M | 1652 | §112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18748562 | ENCAPSULATED BIOFILM COMPOSITIONS AND METHODS | ABDEL LATIF, MAHMOUD MOTAZ | 1773 | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18669423 | SYSTEM AND METHOD FOR DENOISING IN MAGNETIC RESONANCE IMAGING USING A TRANSFORM DOMAIN LOCAL LOW RANK TECHNIQUE | CURRAN, GREGORY H | 2852 | §103 | Non-Final OA | — | Pending | May 20, 2024 |
| 18667481 | SYSTEMS AND METHODS FOR TREATING STORMWATER WITH ANAMMOX BACTERIA | VARMA, AKASH K | 1773 | §103§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18708411 | COMPOSITIONS AND METHODS FOR TRANSCRIPTIONAL ACTIVATION | STEPHENS, REBECCA JOHANNA | 1663 | §103§112DP | Non-Final OA | — | Pending | May 08, 2024 |
| 18654961 | VIRAL ANTIGEN DISPLAY COMPOSITIONS AND METHODS | CORNELIUS, CLAIRE ADRIENNE | 1672 | §103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18649533 | SYSTEMS AND METHODS FOR MODIFYING DAIRY PROTEIN FUNCTIONALITY | BECKER, DREW E | 1792 | §102§103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18705175 | TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS AND USES THEREOF | ONDACHI, PAULINE WANJIKU MUCH | 1627 | §103DP | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18642224 | PRECISION FUNCTIONAL MAPPING (PFM) TO PERSONALIZE NEUROMODULATION IN PSYCHIATRIC AND NEUROLOGICAL APPLICATIONS | CHNG, JOY POH AI | 3686 | §101§112 | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | MCDOWELL, BRIAN E | 1624 | §102§103 | Non-Final OA | 3d overdue | Pending | Apr 18, 2024 |
| 18635934 | ADAPTIVE REAL-TIME STATE SPACE CONTROL OF A NEUROSTIMULATION DEVICE | LEE, BRYAN MCALLISTER | 3796 | §103 | Non-Final OA | 12d | Pending | Apr 15, 2024 |
| 18633908 | THERAPEUTIC COMPOUNDS | MILLER, DALE R | 1693 | §103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18631916 | METHODS AND COMPOSITIONS FOR IMPROVING IMMUNOTHERAPY | LOGSDON, CHARLES | 1662 | §103§112 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18696252 | PARALLEL TRANSMIT RADIO FREQUENCY PULSE DESIGN WITH DEEP LEARNING | PATEL, RISHI R | 2896 | §103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18696138 | STENT AND METHOD FOR SECURING AIR FLOW BY RELIEVING STENOSIS OF RESPIRATORY ORGAN | HU, ANN M | 3774 | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18605241 | METHODS OF FORMING AN OXIDE USING VAN DER WAALS MATERIALS | TALBOT, BRIAN K | 1784 | §103§112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18690594 | SALMONELLA ENGINEERED FOR NONTOXIC COLONIZATION OF TUMORS | STAVROU, CONSTANTINA E | 1632 | §102§103 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18593314 | CONJUGATES AND METHODS OF USE THEREOF | BOWERS, ERIN M | 1653 | §102§103 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18587203 | SUSPENDED PARTICLE CONCENTRATION, DETECTION, AND ANALYSIS | SCHNASE, PAUL DANIEL | 2877 | §103 | Final Rejection | 35d | Pending | Feb 26, 2024 |
| 18438184 | BOTTLEBRUSH POLYMERS AND METHODS THEREOF | KASSA, TIGABU | 1619 | §102§103 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18291525 | BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY | WORSHAM, JESSICA N | 1615 | §102§112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18579604 | MONITORING AND CLASSIFICATION OF CARDIAC ARREST RHYTHM | DIETRICH, JOSEPH M | 3796 | §103§112 | Final Rejection | 31d overdue | Pending | Jan 16, 2024 |
| 18579222 | SYSTEMS AND METHODS FOR CONTROLLING A MEDICAL DEVICE USING BAYESIAN PREFERENCE MODEL BASED OPTIMIZATION AND VALIDATION | BAIG, RUMAISA RASHID | 3796 | §103§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18403891 | HIGHLY FLUORINATED COMPOUNDS FOR 19F MRI-BASED THERMOMETRY | BRAZIN, JACQUELINE | 1798 | §102§112 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18573327 | COPOLYMERS AND DEGRADABLE PLASTICS INCLUDING SALICYLATES | NGUYEN, HA S | 1766 | §102§103 | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18570723 | TARGETED ADAM17 BLOCKER COMPOUNDS, ANTI-ADAM17 ANTIBODIES, METHODS OF MAKING, AND METHODS OF USING | HUYNH, PHUONG N | 1641 | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18571000 | APPARATUSES, SYSTEMS, AND METHODS FOR FASCIAL CLOSURE | DORNBUSCH, DIANNE | 3771 | §103 | Non-Final OA | 9d | Pending | Dec 15, 2023 |
| 18540131 | BEHAVIORAL FORENSICS IN SOCIAL NETWORKS | MINCEY, JERMAINE A | 2159 | §101§103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18536537 | BIO-ENHANCED REMEDIATION AND OIL RECOVERY MODEL SYSTEM AND METHODS | KASS, BENJAMIN JOSEPH | 1796 | §102§103§112 | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18565831 | METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T CELLS | HAM, JIEUN | 1643 | §103§112DP | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18565948 | METHODS, DEVICES AND SYSTEMS FOR SEPARATING BIOLOGICAL ANALYTES FROM SAMPLES | FISHER, BRITTANY I | 1796 | §102§103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18501663 | DEVICE FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND RELATED SYSTEMS AND METHODS | SIRCAR, ALISHA JITENDRA | 3792 | §102§103§112 | Final Rejection | 98d overdue | Pending | Nov 03, 2023 |
| 18558837 | DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) ASSEMBLIES AND INJECTORS WITH FRICTION-REDUCING COATINGS | SHARMA, YASHITA | 3774 | §102§103 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18286955 | Glycan Targets of Serum IgG and IgM Antibodies | WEN, SHARON X | 1641 | §103 | Non-Final OA | — | Pending | Oct 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRegents of the University of Minnesota has 89 pending office actions as of October 2026, spread across 59 art units and 89 examiners.
Yanxin Nmn Shen has the most, with 1 of Regents of the University of Minnesota's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.